Tscan Therapeutics, Inc. · NASDAQ:TCRX
Tscan Therapeutics, Inc. shareholders
As of Jun 30, 2026, 57 institutions reported holding Tscan Therapeutics, Inc., 55.5% of its shares. Largest: Lynx1 Capital Management LP, Bvf Inc and Baker Bros. Advisors LP. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Tscan Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Lynx1 Capital Management LP | 8.02M | 12.3% | no change | Aug 13, 2026 |
| Bvf Inc | 5.56M | 8.5% | no change | Aug 14, 2026 |
| Baker Bros. Advisors LP | 2.78M | 4.3% | no change | Aug 14, 2026 |
| Vanguard | 2.56M | 3.9% | +59,357 | Aug 13, 2026 |
| Two Sigma | 1.95M | 3.0% | +741K | Aug 14, 2026 |
| Renaissance Technologies | 1.33M | 2.0% | −37,984 | Aug 13, 2026 |
| Acadian Asset Management LLC | 1.31M | 2.0% | +1.1M | Aug 13, 2026 |
| Deer Management Co. LLC | 1.25M | 1.9% | no change | Aug 14, 2026 |
| Millennium | 1.16M | 1.8% | −297K | Aug 14, 2026 |
| Jacobs Levy Equity Management, Inc | 1.05M | 1.6% | +241K | Aug 14, 2026 |